Europe — EMA

Nátrium-Glicerin-Foszfát Fresenius (Sodium Glycerophosphate Pentahydrate)

Sodium Glycerophosphate Pentahydrate, the active ingredient in Nátrium-Glicerin-Foszfát Fresenius, is a phosphate donor presented as a sterile powder for intravenous use.

Sodium Glycerophosphate Pentahydrate

Request sourcing

Pack/s

What is Sodium Glycerophosphate Pentahydrate?

Sodium Glycerophosphate Pentahydrate, the active ingredient in Nátrium-Glicerin-Foszfát Fresenius, is a phosphate donor presented as a sterile powder for intravenous use. It is employed to correct hypophosphatemia and support cellular metabolism in hospitalized patients. GNH USA supplies Nátrium-Glicerin-Foszfát Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Nátrium-Glicerin-Foszfát Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Sodium Glycerophosphate Pentahydrate used for?

Sodium Glycerophosphate is used primarily for re‑establishing phosphate levels via the phosphate‑binding pathway.

- Hypophosphatemia: helps restore serum phosphate concentrations in patients with low phosphate levels. - Renal replacement therapy: provides a source of phosphate during continuous renal replacement therapy (CRRT). - Parenteral nutrition: supplies phosphate as part of a comprehensive nutrient formulation. - Post‑

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →